0Q6H Stock Overview
Operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Hofseth BioCare ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 2.16 |
| 52 Week High | NOK 3.35 |
| 52 Week Low | NOK 2.16 |
| Beta | 0.41 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -36.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0Q6H | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 0% | -5.2% | 0.8% |
| 1Y | n/a | -20.1% | 6.6% |
Return vs Industry: Insufficient data to determine how 0Q6H performed against the UK Biotechs industry.
Return vs Market: Insufficient data to determine how 0Q6H performed against the UK Market.
Price Volatility
| 0Q6H volatility | |
|---|---|
| 0Q6H Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0Q6H has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0Q6H's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 70 | Jon Odegard | www.hofsethbiocare.com |
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company’s products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism, and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. The company was incorporated in 2000 and is headquartered in Ålesund, Norway.
Hofseth BioCare ASA Fundamentals Summary
| 0Q6H fundamental statistics | |
|---|---|
| Market cap | NOK 794.11m |
| Earnings (TTM) | -NOK 97.85m |
| Revenue (TTM) | NOK 226.10m |
3.5x
P/S Ratio-8.2x
P/E RatioIs 0Q6H overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0Q6H income statement (TTM) | |
|---|---|
| Revenue | NOK 226.10m |
| Cost of Revenue | NOK 151.04m |
| Gross Profit | NOK 75.07m |
| Other Expenses | NOK 172.92m |
| Earnings | -NOK 97.85m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 23, 2024
| Earnings per share (EPS) | -0.25 |
| Gross Margin | 33.20% |
| Net Profit Margin | -43.28% |
| Debt/Equity Ratio | 104.4% |
How did 0Q6H perform over the long term?
See historical performance and comparison